Date
26 September 2023
Generic companies need to improve access strategies in LMICs, says report
In an article for The Hindu BusinessLine, Jyothi Datta writes about the release of the Foundation's first report from its Generic & Biosimilar Medicines Programme. The article looks at what generic medicine manufacturers need to do in order to ensure their medicines reach the people who need them.
Direct links
The Foundation's CEO, Jayasree Iyer, is quoted throughout the article. On encouraging manufacturers to be more proactive to better serve the needs of specific populations in low- and middle-income countries (LMICs) she says: “Generic companies get involved way too late in a product to be able to serve patients.”
The article looks at one of the key findings from the report that promotes an increase in local manufacturing. This can ensure products are more within reach of patients, and can strengthen supply chains, mitigating the risk of shortages.
Read the Foundation's report on generic and biosimilar medicine manufacturers.